Patients must have tumor tissue available for submission to assess gene expression of ERCC1 and XRCC1; patients must also be offered participation in banking for future use of specimens
Patients must be offered the opportunity to consent to the use of specimens for future research
Patients must have pre-treatment blood and tissue specimens submitted for translational medicine as outlined; with patient consent, residuals will be banked for future research
Patients must be offered participation in banking of specimens for future research; with the patients consent, specimens (serum and bone marrow biopsy core) must be submitted to the repository; patient consent must be obtained before specimens are submitted
Patients must be offered the option to participate in submission of specimens for banking for future translational medicine studies
Patients participating through PK sites, must be offered the option to submit blood specimens for population pharmacokinetic analysis
Patients must be offered the option to participate in the Diet and Lifestyle Substudy
Patients must also be offered participation in banking for future use of specimens
Patients must be offered the opportunity to participate in the ultra pure Circulating Tumor Cells (upCTCs) study
Patients must have specimens submitted for blinatumomab immunogenicity assessment; collection of pretreatment specimens must be completed within 28 days prior to registration to S1318; specimens must be submitted to LabConnect
Patients must be offered participation in specimen submission for future research; with patients consent, specimens must be submitted as outlined
Patients must be offered the opportunity to participate in specimen banking
Sites must seek additional patient consent for the future use of specimens
Patients must be offered the opportunity to participate in specimen banking for future translational medicine studies
Patients must be offered the opportunity to participate in specimen banking for future use
SPECIMEN SUBMISSION CRITERIA: Patients must be offered optional participation in banking of specimens for future research
Patients must also be offered participation in banking for future use of specimens
Patients must be offered the opportunity to participate in specimen banking for future studies to include translational medicine studies
Patients must be offered the opportunity to participate in specimen banking for future studies, to include translational medicine studies
Patients must be offered the opportunity to participate in specimen banking
Patients must also be offered participation in banking and in the correlative studies for collection and future use of specimens
Patients must be offered the opportunity to participate in specimen banking for future research
Patients must have blood and tissue specimens collected prior to registration and submitted for translational medicine; note that patients without adequate diagnostic specimens will not be eligible; with patient consent, residuals from the mandatory submission will be banked for future research
Patients must agree to have blood specimens submitted for pharmacokinetic analysis
